Stockscreener 앱 받기
3.95
8.37%
0.305
시간 외 거래:
3.96
0.010
+0.25%
전일 마감가:
$3.645
열려 있는:
$3.66
하루 거래량:
594.07K
Relative Volume:
1.51
시가총액:
$111.42M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
+14.49%
1개월 성능:
-11.24%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$3.40
$4.05
1주일 범위
$3.30
$4.36
52주 변동 폭
$3.0501
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
명칭
Conexeu Sciences Inc
전화
604-315-4722
주소
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
3.95 | 111.42M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Conexeu Sciences Inc Stock (CNXU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-06-22 | 개시 | H.C. Wainwright | Buy |
Conexeu Sciences Inc 주식(CNXU)의 최신 뉴스
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com India
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com Nigeria
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com South Africa
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com Australia
Form 4 Conexeu Sciences Inc. For: 28 September By Investing.com - Investing.com UK
At $0.001 a share, a Conexeu Sciences (CNXU) executive exercises rights to acquire stock. - stocktitan.net
Conexeu Sciences (NASDAQ:CNXU): What The Bearish Surge Signals? - Kalkine Media
Conexeu Sciences Revises Prospectus for 9.48 Million Shares with Latest Quarterly Report (NASDAQ: CNXU) - Kalkine Media
Conexeu (Nasdaq: CNXU) consultant gets 500K shares at $0.001; more hinge on FDA filing - Stock Titan
Conexeu Sciences (NASDAQ: CNXU) Reports $7.73M Quarterly Loss, Highlights Funding Challenges - Kalkine Media
CNXU 8-K FilingsCONEXEU SCIENCES INC SEC 8-K - Stock Titan
Conexeu Sciences Director Purcell Lynn Sebastian Executes 217,608-Share Deal at $2.30 Each - Kalkine Media
Conexeu Sciences (CNXU) director exercises 217K-share warrant at $2.30 - Stock Titan
Ambarella Q2 Revenue Rises 12% as Net Loss Narrows Sharply - minichart.com.sg
Investment fund caps Conexeu Sciences (CNXU) stake below 10% - Stock Titan
Near-10% stake in Conexeu (CNXU) tied to warrant cap - Stock Titan
Conexeu Sciences (NASDAQ:CNXU) Shares Down 5.2%Here's What Happened - marketbeat.com
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture - TradingView
Conexeu Steps Up Investor Outreach Ahead of Key Regulatory Milestones - TipRanks
Conexeu Sciences Sets September and October 2026 Conference Schedule - The Manila Times
At Nasdaq headquarters, a biotech company will present Sept. 9, then attend two more events. - Stock Titan
Conexeu Sciences (CNXU) pays consultants with $88K in stock - Stock Titan
Conexeu Sciences Inc.: Fundamental Analysis and Financial Ratings | CNXU | US20715F1003 - marketscreener.com
Here's Why We're Not Too Worried About Conexeu Sciences' (NASDAQ:CNXU) Cash Burn Situation - webull.com
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts - Eastern Progress
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It. - The Spec
The Biggest Winners Don't Compete in a Category. They Rewrite It. One Company Is Betting It Can Too. - marketscreener.com
Conexeu Sciences Sees a New Category Forming in Medical Aesthetics as Research Turns to Regeneration - Moomoo
Jeffrey Sharpe Discloses Investment at Conexeu Sciences Inc. with 5.4% Stake - TradingView
2.3M-share stake in Conexeu Sciences (CNXU) revealed by single investor - Stock Titan
Conexeu (CNXU) director gets $0.001 warrants tied to Nasdaq, FDA goals - Stock Titan
CNXU - Finviz
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It. - GlobeNewswire
Conexeu Sciences Inc. (CNXU) BetaZacks.com - Zacks Investment Research
CNXU : Conexeu Sciences Inc. Key Company Details - Zacks Investment Research
Conexeu Sciences (CNXU) investor reports 12.3% stake and warrant-linked shares - Stock Titan
Conexeu Sciences Inc. (CNXU) investor discloses 5.5% stake in Schedule 13G filing - Stock Titan
OnePointTwo Capital Ventures (CNXU) discloses 1.88M-share Conexeu Sciences stake - Stock Titan
One Platform, Five Markets: Insights Into Conexeu Sciences Inc. - smallcapasia.com
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - marketscreener.com
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - GlobeNewswire
Conexeu to Present at 2026 Controversies & Conversations in Laser and Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - marketscreener.com
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It - marketscreener.com
Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium - TipRanks
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - The Manila Times
Beyond volume: Conexeu to discuss the body's repair process - Stock Titan
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GT Biopharma’s TriKE® Program: Pipeline, Progress, & What’s Ahead - smallcapasia.com
Price to earnings forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One - Investing News Network
Conexeu Sciences Inc (CNXU) 재무 분석
Conexeu Sciences Inc (CNXU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Conexeu Sciences Inc 주식 (CNXU) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Sharpe Jeffrey Nathan | Director |
Sep 14 '26 |
Option Exercise |
0.00 |
500,000 |
500 |
1,500,000 |
| Purcell Lynn Sebastian | Director |
Jun 18 '26 |
Buy |
0.80 |
202,500 |
162,000 |
2,734,240 |
| Wright Michael G. | 10% Owner |
Jun 18 '26 |
Option Exercise |
0.00 |
250,000 |
250 |
2,148,048 |
| Wright Michael G. | 10% Owner |
May 26 '26 |
Option Exercise |
0.00 |
400,000 |
400 |
1,898,048 |
| Sharpe Jeffrey Nathan | Director |
May 22 '26 |
Option Exercise |
0.00 |
500,000 |
500 |
1,000,000 |
1.35%
자본화:
|
볼륨(24시간):